Seeking AlphaTue, 07 Apr 2026 03:22:55 GMTCardiff Oncology: Market Dismisses Onvansertib's Potential In First-Line Colorectal CancerCRDF+2.50%
Seeking AlphaThu, 26 Mar 2026 10:25:57 GMTCardiff Oncology, Inc. (CRDF) Discusses Advances in First-Line Treatment for RAS-Mutated Metastatic Colorectal Cancer and Clinical Data on PLK1 Inhibitor TranscriptCRDF+2.50%